Skip to content
Search

Latest Stories

Medical Devices Bill that widens prescribing powers introduced

The new Medical Devices Bill introduced in the parliament on Friday suggests increasing the range of professions able to prescribe medicines in low-risk.

A Department of Health and Social Care (DHSC) statement said it will be similar to what midwives and paramedics do now with pain relief and physiotherapists with anti-inflammatories. However, so far there is no official confirmation about pharmacists being included.


According to the DHSC, there will be safeguards and limits on what medications are eligible. The government will work with the NHS and stakeholders to determine what medicines could be eligible and in what circumstances, it added.

The bill, which was announced in the Queen’s speech in October 2019, introduces new regulations on medical devices, such as pacemakers, breast implants and ultrasound imagers, to ensure patient safety and also gives NHS hospitals the power to use innovative, personalised medicines for unique cancers and diseases.

This means hospitals can use patient tissue and DNA samples to tailor treatments to individual patient when other medicines have failed or to develop drugs that have a shelf-life of minutes and would otherwise be unavailable to the patient.

The regulations related to medical devices asks companies to register medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA) and ensures suppliers follow strict safety checks and enables tough enforcement action if something goes wrong.

The Health Secretary will have the power to disclose specific information about devices to the members of the public and the healthcare system, subject to appropriate safeguards, when there are serious patient safety concerns.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less